Ercu et al. summarized how mutations in the PDE3A gene contribute to hypertension and suggested that PDE3A-directed strategies could be utilized to treat essential hypertension and prevent hypertension-induced cardiac damage [35]. This evidence concerns the gene PDE3A and hypertensive disorder.